chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received shot about 5 p.m. - at 7 p.m. appeared pale and complained of being tired; slept 7-10 p.m. at 10 p.m. complained of feeling nauseated, felt dizzy at midnight appeared pale, the "walls looked weird, fuzzy."
NERVE PAIN; FEVER; CHILLS; BODY ACHE; HEADACHE; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 08-MAR-2021, the subject experienced nerve pain. On 08-MAR-2021, the subject experienced fever. On 08-MAR-2021, the subject experienced chills. On 08-MAR-2021, the subject experienced body ache. On 08-MAR-2021, the subject experienced headache. The symptoms started developing around 7:00 PM of the same day of the administration.  Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from fever, and chills, and the outcome of nerve pain, body ache and headache was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment is not required as per standard procedure as case assessed as non-serious
reported that doses of GARDASIL9 had been administered following a temperature excursion; This spontaneous report has been received from a health professional, referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, previous drug and/or allergy reactions were not reported.  On 09-AUG-2021, the patient was vaccinated with an improperly stored hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) at a dose of 0.5 milliliter (vaccination scheme, route and anatomical location of administration were not provided; lot # T026167 has been verified to be a valid lot number, and expiration date reported and established upon internal review as 04-DEC-2022) as prophylaxis.   The administered vaccine underwent a temperature excursion below 2 degrees Celsius (°C) of -40.0 °C for a time frame of 15 minutes; and an excursion above 8°C of 9.6 °C for a time frame of 1 hour. No previous temperature excursion was reported. No information about the use of a datalogger was reported.   This is one of several cases, from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. devicelotnumber: T026167; expirationdate: 04-DEC-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Worst throbbing Migraine; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Worst throbbing Migraine) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced MIGRAINE (Worst throbbing Migraine). The patient was treated with CAFFEINE, PARACETAMOL (EXCEDRIN ASPIRIN FREE) at an unspecified dose and frequency. At the time of the report, MIGRAINE (Worst throbbing Migraine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021; Patient received Moderna vaccine past its 30 days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2022 at 12:51 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 28-Jan-2022 at 12:51 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received Moderna vaccine past its 30 days expiry date) and PRODUCT STORAGE ERROR (Received vaccine past its 30-days Exp date Vaccines went into 2-8 C thaw state on or about 24-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 04-Apr-2022.   No treatment medication was reported by reporter.
Information has been received from a physician via a company representative referring to a female patient of unknown age. The patient's pertinent medical history and drug reactions/allergies were not provided. On 06-JUN-2016, the patient received an injection of PNEUMOVAX 23 (lot # L035686, expiration date February 2017), subcutaneously. On the same date, the patient had an adverse event which was further specified as arm "became red, hot and her biceps were swollen and hard". The outcome of the events and the causality were not reported. Additional information is not expected since the physician does not want to be contacted.
patient received dose 2 of the moderna vaccine and waited the required 15 mins, in which no symptoms appeared. As she went to leave, she felt as if her throat was closing up. She received one dose of 50mg IM Benadryl, followed by a second dose administered 15 mins later. Symptoms resolved and she left after 45 mins of observation
I tested positive for COVID on May29, 2022. I had a sore throat, cough, runny nose, aches.  I was given Paxlovid, and am still taking it. I still have symptoms.
Information has been received from a licensed practical nurse, concerning an 11 year old female patient with seasonal allergies, who on 04-JAN-2008 was vaccinated IM, with the first dose, 0.5 of Gardasil (lot #657868/0523U).  Concomitant therapy included ZYRTEC.  On 23-JAN-2008 the patient developed a small node on her left clavicle, and was afebrile.  On 25-JAN-2008, she was seen in the office with a supraclavicular lesion.  On 08-FEB-2008, a biopsy and removal of the node was performed as outpatient at the hospital.  The biopsy revealed a "benign reactive hyperplastic node."  The patient recovered from the events (date and duration not specified).  On 05-MAR-2008, the second dose, 0.5 ml, IM, of Gardasil (lot # 658556/1060U) was administered.  The reporter considered the events to be serious as an other important medical event.  Additional information has been requested.
Breakthrough case admission after 3 vaccines Moderna 3/1/21 Lot# 010A21A;  Moderna 3/29/21 Lot# 018B21A;  Moderna 10/31/21 Lot# 939905
Patient is fully vaccinated. Admission dx:  shortness of breath, hypokalemia, atrial fibrillation with RVR. COVID 19. Placed on steroids with remdesivir.  Oxygen returned to room air, and placed on Xarelto and cardizem.  discharged in stable condition.
This spontaneous report as received from a medical assistant refers to a 12 month old patient. On an unknown date the patient was vaccinated with first dose of PROQUAD (dosage information and lot number unknown) and a dose of VARIVAX (Merck) (dosage information and lot number unknown) on the same office visit. No adverse effect reported. It was unknown if the patient had sought medical attention. Additional information has been requested.
Patient received Moderna COVID-19 vaccine and within 5 minutes patient complained of fast heart rate and feeling "not right".  Patient blood pressure at time 156/88 with heart rate 114.  Patient given cool rag and then complained of tingling to her arm and hands and numbness to tongue.  Patient was taken to Medical Center Emergency Room and given Epinephrine 0.3 mg per Auto-injector.  Patient was then given Solumedrol 125 mg and Bendaryl 25 mg slow IVP.  Patient observed in the ER and didn't experience any rash or swelling of lips and/or tongue.
Redness at injection site as per MD it looks infected. MD prescribe BACTROBAN applying TID.
Head Cold, Sinus Congestion Sore Throat, Cough. All those sytems ran its course from 3/12/21-3/17/21. Now I have consistent shortness of breath having to use prednisone, Asthma inhaler and nebulizer for short time relief. I have reached out to my PCP Yesterday and was advised if Breathing issues and SOB did not resolve to call him back today. It has gotten worse and now I will see him again today.
Transcient Gobal Amnesia on 1/9/2021 resolved in 8 hours
Information has been received from a pharmacist concerning his 66 year old wife with codeine allergy and no pertinent medical history who on 19-JAN-2011 was vaccinated SC with a dose of ZOSTAVAX (Merck) in her left arm. Concomitant therapy included PREVACID. On 22-JAN-2011 the patient developed shingles after receiving ZOSTAVAX (Merck). It was reported that she received the vaccine in the left arm and painful rash developed from left knee to hip. The patient sought unspecified medical attention. The patient was treated with tramadol and acyclovir. At the time of this report, the patient's shingles persisted. Follow-up information has been received from a physician concerning the 66 year old female with no illness at the time of vaccination who on 19-JAN-2011 was vaccinated with ZOSTAVAX (Merck). Concomitant therapy included PREVACID, amitriptyline hydrochloride, vitamins (unspecified) and calcium (unspecified) (+) vitamin D (unspecified) and another unspecified medication (handwriting illegible). The physician reported that the vaccination was not given by himself. The physician wrote the patient a prescription and the vaccination was given by a pharmacy. On 21-JAN-2011 the patient experienced left knee, left low back, left lateral hip, left medial thigh upper pain, vesicular rash on left medial thigh (handwriting illegible), thigh, hip and low back pain and the developed shingles. No specimen was obtained. No diagnostic test or labs were performed. The outcome was not reported. No further information is available.
Eyes dilated, vision fuzzy around edges of object, perception off.  Feel very lethargic,
Itching on first night.  Second  day rash on body from neck to top of thighs.  Whole trunk. Severe itching
Swollen shot area for 2 days, became cranky, runny nose, stool changed to army green then slate gray, rash on bottom. Almost 2 weeks later she got a fever, loss of appetite and restless sleep. All of this was within a 17 day time frame. She was back to normal on day 20. Reported events to Dr. during and after the 17 days. *Sofia has been on an alternate vaccine schedule since birth. She receives only 1 vaccine per month.
Narrative: Patient received Janssen vaccine on 04/09/2021; upon follow-up call with nurse the patient reported fever and chills that lasted 36 hours after vaccination administration. Patient did not report taking any medication for symptom management and denied any symptoms at time of follow-up call.
Right thigh is red, hot to touch and swollen and hard. Attending physician prescribed Augmentin for secondary infection on 2/17/2000.
Swelling of tongue & throat; numbness of face. BP 145/103; HR 1212; RR 23. Allergic to Lamictal. Given Benadryl 25mg PO x1. Sx resolved, released home & recommended follow up with PCP. 2nd dose of Moderna cancelled & made appt for J&J in 28 days
Subsequent to receiving one dose of varicella virus vaccine live the pt developed a mild case of chickenpox with greater than 20 vesicular lesions and fever. The lesions were located on his trunk, face and extremities.
Sore left shoulder not relieved by ice/heat/anti-inflammatories, tightness going up into back of neck
body aches, nasal congestion/pressure, red eyes, loss of taste, headache. starting 12/4/21
Information has been received from a physician concerning a 16 year old female patient who on 05-NOV-2008 was vaccinated with the second dose of GARDASIL (lot# 659655/1486U). Concomitant therapy included VARIVAX and ADACEL. On 21-NOV-2008 the patient developed rash, hives, urticaria and generalized joint pain in her knees, elbows and ankles, but she had no fever. The patient was instructed to take TYLENOL for the pain and she was referred to an urgent care physician who instructed the patient to take BENADRYL. On unspecified date lab tests were performed, but specifics are unspecified. As of 24-NOV-2008 the patient had not recovered. The physician considered the patient's experience to be disabling because "it was hard for the patient to walk". Additional information has been requested.
patient complained of flu-like symptoms including diarrhea, aching head-to-toe, dizzy, light-headed and muscle pain at injection site;  patient self-treated with Tylenol ES, rest, and increased fluid intake; still experiencing these effects at 12:20pm 5/20/2020
Patient states that the whole arm is sore and is getting progressively worse. Since last night (11/30) he now has tingling and numbness in fingers.
Area of injection became red, lg hard lump and itchy. Lump and redness have increased since day of injection.
2 hours after receiving her 2nd SHINGRIX injection patient began having severe artralgias in all major joints. Neck pain and dizziness/vertigo. Patient felt like she had a high fever with heat radiating from her skin this continued for 4 days after the injection. On 4th day dizziness subsided to point where she could return to pharmacy to tell me about it. Patient did not take her temperature or seek medical attention.
Eve of 10/10...Slight flu like symptoms. 10/11 morn left upper sore/achy. Later that eve arm continued to be sore but about 7 welts were noted scattered near the injection site & under the axilla. No itching - I took 37 mgr BENARYL & two TYLENOL - Welts faded after that after 2 days.
Reported that he began to feel dizzy after injection. Was taken to urgent care clinic for monitoring. Was noted to be hypertensive. Was monitored and blood pressure returned to safe level within 30 minutes. Was discharged home.
pt recv vax 24OCT95 & devel a feeling that lips were swollen (paresthesia w/pins & needles);pt's blood pressure was also elevated to 160/100;pt does have a hx of labile hypertension;upon exam by MD there was no visible swelling of lips;
Information has been received from a medical assistant and a physician referring to an unspecified number of patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored (wistar ra 27-3) M-M-R II (lot # L036851 with expiration date 23-SEP-2017, lot # L040960 with expiration date 16-OCT-2017; dose and route were not reported). The doses of (wistar ra 27-3) M-M-R II were exposed to 8.24 Fahrenheit for 15 days. There was no previous temperature excursion. No adverse effects were reported. Additional information has been requested.
pt recvd 2nd dose of Hep B vax on 4FEB92 & exp stinging pain @ the site of the inject;
Case number PHEH2014US015546 is an initial spontaneous report received from a nurse on 30 Jul 2014. This report refers to a 17 year old female patient. Past medical history and concomitant medications was not reported. She received only Men A lyophilized conjugate component of MENVEO (batch number: A13016), intramuscularly reconstituted with a sterile water instead of MenCYW-135 liquid component on 30 Jul 2014. No adverse reaction reported following this administration error.
This spontaneous report was received from a physician and refers to a 23 year old female patient. There was no information regarding the patient's medical history, concomitant medications, drug reactions or allergies provided. On 01-SEP-2017, the patient was vaccinated with a second dose of GARDASIL 9 intramuscularly for prophylaxis (lot number and expiration date were not reported). On an unknown date in September 2017 (reported as after the injection), the patient experienced syncope. The physician did not provide information about specific treatment. On 13-SEP-2017, the patient visited physician's office. She was doing well and deemed as recovered. The relatedness between the event and GARDASIL 9 was assessed as related (physician stated that no other condition was found as possible reason for the syncope experience).
This is a spontaneous report from a contactable Pharmacist via Pfizer sales representative. An adult patient of an unspecified ethnicity and gender received PREVNAR 13, via an unspecified route of administration on an unspecified date at a single dose for immunisation. The patient medical history and concomitant medications were not reported. The patient experienced felt heat and a rash at the injection site on an unspecified date with outcome of unknown. No follow up attempts possible. No further information expected.
1/26/22-66 yr/o male with no significant past medical history presenting for evaluation of respiratory distress. Patient states he has been feeling increasingly unwell for approximately 1 week. He notes increasing dyspnea. Associated with a productive cough. He does have sharp pain in the center of his chest. Does not radiate. He notes body aches as well. He has been exposed to Covid. He is vaccinated for Covid. EMS reports room air sats in the seventies. Improved to the mid eighties on a nonrebreather Review of Systems  Constitutional: Negative for chills and fever.  HENT: Negative for congestion, ear pain and sore throat.   Eyes: Negative for discharge.  Respiratory: Positive for cough and shortness of breath. Neg  Review of Systems, Respiratory: Positive for cough and shortness of breath. Negative for wheezing. Cardiovascular: Positive for chest pain. Negative for palpitations. Gastrointestinal: Negative for abdominal pain, constipation, nausea and vomiting. Endocrine: Negative for polydipsia. Genitourinary: Negative for dysuria and urgency. Musculoskeletal: Positive for myalgias. Negative for back pain and neck pain. Skin: Negative for rash. Neurological: Positive for headaches. Negative for dizziness, seizures and weakness. Hematological: Does not bruise/bleed easily. All other systems reviewed and are negative. Plan: 1.  Acute respiratory failure-Placed on BiPAP.  Admitted to ICU. CT of chest noted above. Therapeutic Lovenox, IV antibiotics and Decadron initiated in ED.  Pending Covid test.  Pulmonary consulted for further evaluation.  Contact precautions per protocol. 2.  Elevated troponin-EKG without ischemic changes.  Continue to monitor on telemetry. 3.   Hypokalemia-replace per potassium protocol. 4.
Received Immunizations on 06/29/2004 in on 6/30/2004 parent noticed site of injection was warm/red/itchy and hard in afternoon. On 7/1/04 mother noticed that it was white around the shot with a red ring on the outside. Still tender and swollen.
Pt vaccinated with Influenza lt arm felt sore & noted headache in the region & bilateral neck pain posterior. Also noted chills - did not take temp pt woke up feeling as if couldn't breathe & had a cement block on chest.
right upper eyelid and forehead area swelling with one papule; right upper eyelid and forehead area swelling with one papule; papule; This is a spontaneous report from a contactable other hcp.   A 60-years-old female (non- pregnant) patient received bnt162b2 (BNT162B2 Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 27Jan2021 10:00 (Batch/Lot Number: EL3246) as DOSE 2, SINGLE for covid-19 immunisation (60yeras at the age of vaccination). Medical history included hyperthyroidism from an unknown date and unknown if ongoing , alopecia areata from an unknown date and unknown if ongoing , gastrooesophageal reflux disease from an unknown date and unknown if ongoing , irritable bowel syndrome from an unknown date and unknown if ongoing , osteoarthritis from an unknown date and unknown if ongoing , osteoporosis from an unknown date and unknown if ongoing , hyperlipidaemia from an unknown date and unknown if ongoing , raynaud's phenomenon from an unknown date and unknown if ongoing , herpes zoster from 15Dec2020 to an unknown date involving right upper eyelid, temple area and hairline. Concomitant medication(s) included pravastatin sodium (PRAVASTATIN NA) 20 mg taken for an unspecified indication, start and stop date were not reported; esomeprazole sodium (NEXIUM [ESOMEPRAZOLE SODIUM]) 20 mg taken for an unspecified indication, start and stop date were not reported; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) taken for an unspecified indication, start and stop date were not reported; biotin (BIOTIN) taken for an unspecified indication, start and stop date were not reported. The patient previously took cleocin s and experienced drug hypersensitivity, bnt162b2 for covid-19 immunisation. The historical vaccine include BNT162B2 (Product: Covid 19, Brand Pfizer, lot Number:  EL1284, Administration Time : 10:00 AM, vaccination Location: Left arm, Dose : 01) for COVID-19 immunisation (At 60 years) on 06Jan2021. The patient experienced right upper eyelid and forehead area swelling with one papule, right upper eyelid and forehead area swelling with one papule and papule on 07Feb2021 07:00.  No treatment received for the events. The outcome of the events was not resolved.   Follow-up attempts are completed. No further information is expected.
pt recvd vax 9FEB93 & devel severe pain in arm & elbow; MD felt pt's arm was swollen; MD postulized that a local react in muscle caused it to swell; lt had also felt colder than rt hand & color changed;
pt recv vax;devel rash & fever x 2 days p/ vax;to er 8 days later;cont fever & rash;dx w/ erythema multiforme & tx w/ dph & apap;
fever; ankles hurt; This is a spontaneous report from a contactable consumer or other non-Hcp. This Contactable consumer reported for an unknown male patient. A male patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection) via an unspecified route of administration on an unspecified date (Lot number: Unknown, Expiry date: Unknown) as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced fever and ankles hurt on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient said he broke out in a rash and bumps the next day. He said he came back from the doctors with his lab tests and they confirmed it is dermatomyositis. Possible reaction from the FLUARIX QUAD specifically.